Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR for acute pain from vertebral compression fractures
NCT00771758Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in acute pain (3 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Sum of Pain Intensity Difference Over 3 Days at 72 hours. Started Sep 2008; status: completed.
02
Drugs
tapentadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00771758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771758.